Stock screenerAll disclosures →
EDGAR →
BCDA
Conviction 18HealthcareScan · Thu, Jun 25, 2026BCDA$1.09+2.83%
ResistanceSupportVol 14Insider buyVol MA14 12.29M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.09
Change+2.83%
Gap+4.72%
Rel volume0.01×
Avg volume8.63M
Avg $ vol8.79M
SMA 200.9244
SMA 501.02
SMA 2001.25
Price vs 50+6.72%
Price vs 200-13.07%
MA stackmixed
50/200 cross—
Supertrendup · 0.7124
RSI (14)62
MACD hist0.03
MACD crossbull · 6d
Stoch %K / %D31 / 27
ADX (14)40
+DI / −DI42 / 14
RSI divergenceBullish
MACD divergence—
ATR %+10.35%
ADR %13.02%
52w high2.42
52w low0.7951
From 52w high-54.96%
Above 52w low+37.09%
New 52w highNo
SqueezeOff
Bollinger width33.19%
%B1.04
Donchian pos30.63%
Donchian high1.80
Donchian low0.7765
AVWAP (52w high)1.29
vs AVWAP high-15.69%
AVWAP (52w low)0.9665
vs AVWAP low+12.77%
OBV trendUp
Chaikin MF (20)-0.86
Today vs 20d0.01×
Avg vol (14d)12.29M
Avg vol (20d)8.63M
Avg $ vol (20d)8.79M
Market cap12.4M
RS 3m (vs SPY)-24.29%
RS 6m (vs SPY)-24.27%
RS line new highNo
Trend template2/8
Technical rank47.8
1 week+15.03%
1 month+19.64%
3 months-9.17%
6 months-15.50%
1 year-50.00%
YTD-14.17%
P/E-1.51
P/B-11.63
P/S25.88
P/FCF-1.67
EPS-1.23
Div yield—
ROE771.86%
ROA-480.61%
Debt/Eq—
Current0.41
EV/EBITDA-1.39
Gross margin12.94%
Net margin—
Rev growth-16.84%
EPS growth-3.55%
Price target15.50
Target upside1322.02%
Analyst ratingBuy
Institutional5.53%
Ent. value11.45M
Revenue130K
Net income-2.26M
Gross profit69K
Free cash flow-7.44M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.37M
Employees21
ListedWed, Oct 25, 1995
Free float7.86M
Float %71.8%
Short interest329.38K
Days to cover2.7d
Short volume53.6%
Squeeze score31 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.21 vs −$0.17
Last surprise-23.5% miss
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank47.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.48
Support0.8085
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BCDA
No recent disclosed trades by Congress in BCDA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BCDA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
STERTZER SIMON H Director · Common Stock · 2026-06-23 | Buy | 39K | $39K | 2026-06-23 | 2026-06-24 |
STERTZER SIMON H Director · Common Stock · 2026-06-22 | Buy | 70.2K | $65K | 2026-06-22 | 2026-06-24 |
Altman Peter President and CEO · Common Stock · 2026-06-18 | Buy | 800 | $768 | 2026-06-18 | 2026-06-22 |
Altman Peter President and CEO · Common Stock · 2026-06-17 | Buy | 1.5K | $1K | 2026-06-17 | 2026-06-22 |
Altman Peter President and CEO · Common Stock · 2026-06-09 | Buy | 5K | $4K | 2026-06-09 | 2026-06-09 |
Altman Peter President and CEO · Common Stock · 2026-05-20 | Buy | 1.5K | $1K | 2026-05-20 | 2026-05-21 |
Altman Peter President and CEO · Common Stock · 2026-05-19 | Buy | 200 | $190 | 2026-05-19 | 2026-05-21 |
Altman Peter President and CEO · Common Stock · 2026-05-18 | Buy | 5.7K | $5K | 2026-05-18 | 2026-05-18 |
Altman Peter President and CEO · Common Stock · 2026-05-15 | Buy | 5.1K | $5K | 2026-05-15 | 2026-05-15 |
Altman Peter President and CEO · Common Stock · 2026-04-29 | Buy | 5K | $6K | 2026-04-29 | 2026-04-29 |
SEC filings
EDGAR filings in BCDA · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.